The Next Frontier of Trauma: Rethinking Emergency Surgery for Microgravity.

Author: Arthur Alves de Carvalho e Silva

Medical Student and Researcher with a deep interest in human space exploration.

Series: The Interplanetary Surgeon, Part 2 of 3

There is a thought experiment that I find useful when trying to explain space surgery to colleagues who have not encountered the problem before. I ask them to picture a patient in haemorrhagic shock: falling pressure, a rapidly narrowing window for intervention. Standard trauma. Now I ask them to add the following: the operating environment is sealed, the size of a large camper van, and potentially hundreds of millions of kilometres from the nearest blood bank. There is no anaesthetist in the room. The patient is not lying on a table. And the blood, once it leaves the vessels, does not fall.
​That last detail is the one that tends to stop people. It seems almost cinematic, a detail from a science fiction film rather than a clinical problem requiring engineering solutions. But it is entirely real, and it concentrates in a single physical fact the complexity of what performing emergency surgery in microgravity actually requires. Understanding why takes us into a set of problems that are simultaneously physical, physiological, and clinical, and that the research community has been working to solve for longer than most people realize.

Fluid Dynamics and the Microgravity Surgical Field
The behaviour of blood in weightlessness was one of the first problems confronted by space surgery researchers during early parabolic-flight experiments. The foundational work of Campbell, Billica and colleagues at NASA Johnson Space Center established what has become a bedrock principle: open surgery in microgravity requires, at minimum, a reliable system to restrain both the patient and the operator, and a fluid containment strategy.
Without gravity to pool blood at dependent surfaces, bleeding behaves differently: surface tension can cause blood to form globules or domes that adhere to the wound, while droplets, particularly from arterial bleeding, may escape into the surrounding surgical field and potentially the spacecraft atmosphere. The consequences are not merely surgical; they are a crew-safety issue.
The response to this problem has shaped the entire trajectory of space surgery research. Minimally invasive approaches, which confine the surgical field to the interior of a body cavity, have attracted sustained attention precisely because they address the containment problem at its source. Laparoscopic surgery in microgravity has been demonstrated as feasible in parabolic-flight environments, with some important caveats around technique and instrument behaviour.
The 2024 deployment of the MIRA robotic surgical platform to the International Space Station marked the first deployment of a surgical robot in space. The system performed simulated surgical tasks in autonomous and remotely operated modes, providing an important proof of concept for robotic surgery in microgravity. Formal comparative performance data from the deployment are still awaited.
For open surgical approaches, the University of Louisville group led by George Pantalos has spent years developing the Surgical Fluid Management System (SFMS), designed to enclose the operative field within a sealed environment and prevent blood and other fluids from escaping. The system has undergone repeated testing aboard Zero Gravity Corporation parabolic flights and, in 2021, an automated version was tested during a suborbital flight aboard Virgin Galactic's VSS Unity SpaceShipTwo. These experiments demonstrate that the engineering problem is tractable. The distance between an experimental system demonstrated during brief periods of weightlessness and a mission-ready surgical capability that could function reliably throughout a three-year Mars mission is, however, still significant.

Figure 1. AI-generated concept illustration of a contained surgical field designed to limit the escape of blood and other fluids during surgery in microgravity.

The Haemorrhage Problem: Physiology Before Physics
​The physical challenge of fluid containment is real and important. But the physiological challenge of managing haemorrhagic shock in a microgravity-adapted patient may be the more fundamental problem, and it is the less often discussed one.
Astronauts undergo a rapid redistribution of body fluids on entering microgravity, with fluid shifting from the lower body towards the chest and head. As the cardiovascular system adapts, plasma volume typically falls, with reductions of around 10–15 per cent commonly reported during spaceflight. This is not a dramatic physiological alteration in a healthy person performing normal mission tasks. In the context of haemorrhagic trauma, however, it may be significant: the physiological reserve available to buffer acute blood loss could already be reduced before the first drop is shed.

Figure 2. AI-generated concept illustration showing the redistribution of body fluids towards the upper body in microgravity

There is a further and less well-characterised problem: we do not know with confidence how the cardiovascular system of a microgravity-adapted astronaut responds to haemorrhagic shock. The baroreflexes, vascular responses and other compensatory mechanisms that help defend blood pressure are altered during adaptation to microgravity. Whether these systems respond to major haemorrhage in exactly the same way as they would in a terrestrial patient remains uncertain.
NASA's exploration medical-risk modelling identifies trauma among the conditions that can contribute substantially to overall mission medical risk, particularly when evacuation and access to definitive care are limited.

The pharmacological dimension compounds this. Haemostatic agents developed for Earth-based trauma care, from Combat Gauze to tranexamic acid protocols, have not been systematically validated for the space environment. Drug stability during long-duration storage in the radiation environment of deep space remains a concern, although the effects of prolonged radiation exposure are not yet fully understood. Pharmacokinetics may also change in microgravity because the volume of distribution for some drugs could be altered by the fluid shifts of weightlessness. A dosing protocol calibrated for a terrestrial patient may therefore be miscalibrated for a patient who has spent nine months in transit to Mars. Recent research has even begun exploring whether extraterrestrial regolith, the surface material of the Moon or Mars, might serve as a haemostatic agent for missions where resupply is impossible. The fact that this question is being seriously investigated tells you something about the resource constraints the field is working within.

Figure 3. AI-generated concept image illustrating the potential use of extraterrestrial regolith in research into haemorrhage control

Anaesthesia in a Closed System
​The anaesthetic challenge of space surgery deserves particular attention, partly because it sits at the intersection of almost all the other problems described here. General anaesthesia in a sealed spacecraft introduces risks with no terrestrial equivalent. Anaesthetic gases would need to be carefully contained within a closed-loop life-support system, a problem categorically different from the open atmospheric dispersion possible on Earth. The availability of monitoring technology is also constrained by mass, volume and power budgets.

A recent mini review, published in Frontiers in Physiology in early 2026, examined specifically the potential behaviour of spinal anaesthesia in microgravity, where the relationship between drug baricity, posture, spinal curvature and cerebrospinal fluid dynamics that determines block spread on Earth is fundamentally altered by the absence of gravity-dependent density gradients. The review's conclusion is not that regional anaesthesia is infeasible in space but that the terrestrial assumptions underlying current regional anaesthetic practice may fail in microgravity in ways that are not yet characterised. Adapting regional techniques to the space environment requires research that has not yet been done.
The practical implication is that the space surgeon may need to function as their own anaesthetist, or train crew members to assist with anaesthesia administration under protocols designed for non-specialists in a resource-limited environment. Neither of those scenarios has been systematically trained for. Neither has an established protocol. 

What the Evidence Base Actually Supports
​It is important not to overstate the uncertainty. The evidence base for space surgery, while incomplete, is not negligible. Surgical motor skill does not appear to be significantly degraded by microgravity per se, provided the operator is properly restrained relative to the patient. Basic procedures including suturing, haemorrhage control and laparoscopy have all been demonstrated as feasible in parabolic-flight conditions. The robotic surgical approach offers genuine promise because it addresses the containment problem structurally and may eventually support greater procedural autonomy to help overcome the communication latencies of deep space.

Figure 4. AI-generated concept illustration of robotic surgical techniques in a spaceflight environment.

​What the evidence base does not yet support is a complete, validated, mission-ready surgical capability for an interplanetary crew. The gap between feasibility demonstration in short parabolic flight arcs and reliable procedural performance over the duration of a Mars mission will need to be bridged by research that is still ongoing, in some areas barely begun. The physiological unknowns around the critically ill long-duration space patient are substantial. The pharmacological uncertainties are real. The training framework for the space surgeon has not been written.
These are not reasons for pessimism. They are a research agenda. And understanding them clearly, with the specificity that the literature supports rather than the vagueness that makes the problem seem either trivial or intractable, is the prerequisite for building what still needs to be built. What that requires is the subject of the next and final post in this series.

The Interplanetary Surgeon | Part 2 of 3

Missed Part 1? Read No Medevac from Mars: Why Medical Autonomy Will Be Essential for Deep-Space Missions.
​
Read Part 1: No Medevac from Mars →